4893 items matching your search terms.

Will US smoking prevalence "inexorably continue to decline"?

Clements, M. Armstrong, P. Marschner, I.

Design, patient characteristics and run-in responses to treatment in FIELD: a large-scale trial of fenofibrate effects on cardiovascular disease in type 2 diabetes

Colman, P.G. Beller, E.M. Best, J. Scott, R. Davis, T. D'Emden, M. Keech, A.

Pravastatin reduces major coronary events in patients with low levels of both high-density lipoprotein cholesterol and low-density lipoprotein cholesterol: results from the LIPID study

Colquhoun, D Marschner, I Simes, J Glasziou, P Keech, A White, H Barter, P Tonkin, A for the LIPID study investigators,

Pravastatin reduces major coronary events in patients with low levels of both high-and-low density lipoprotein cholesterols (HDL-C, LDL-C): the LIPID Study

Colquhoun, D.; Marschner, I.; Simes, J.; Glasziou, P.; Keech, A.C.; White, H.; Barter, P.; Tonkin, A.; for the LIPID study investigators,

Prognostic assessment of patients with coronary heart disease: results from the LIPID study

Colquhoun, D.; Marschner, I.; Simes, J.; Keech, A.C.; Glasziou, P.

Myocardial infarction due to saphenous vein graft compression by an extracardiac mass

Cox, N. Hughes, C. Keech, A.

Evidence-based medicine: useful tools for decision making

Craig, J. C. Irwig, L. M. Stockler, M. R.

Basic treatment equivalent (BTE) - a better measure of linear accelerator workload

Delaney, G. Gebski, V. Jalaludin, B. Griffiths, S.

To BTE or not BTE: that is the question [letter]

Delaney, G Gebski, V Langlands, A

Direct thrombin inhibitors in acute coronary syndromes and during percutaneous coronary intervention: design of a meta-analysis based on individual patient data

Direct Thrombin Inhibitor Trialists' Collaborative Group,
AMERICAN HEART JOURNAL, 2001     DOI:10.1067/mhj.2001.111954

The FIELD study-final patient demographic data on completion of randomisation

Drury, P.L. Lintott, C.L. Keech, A.C. on behalf of the forty NZ Study Coordinators and Principal Investigators

Reducing psychological distress in a genetic counseling consultation for breast cancer

Duric, V. Butow, P. Sharpe, L. Lobb, E. Tucker, K. Meiser, B. Barratt, A.

Patients' preferences for adjuvant chemotherapy in early breast cancer: a review of what makes it worthwhile

Duric, V Stockler, M

The bottom line: outcomes following conservation therapy in anal cancer

Dwyer, MK Gebski, VJ Jayamohan, J

Phase II study of irinotecan, leucovorin and 5-fluorouracil in advanced gastric cancer.

Findlay, MPN Ackland, S Gebski, V Yuen, J Boyer, M Walpole, E Wilcken, N Zalcberg, J Australasian Gastrointestinal Trials Group (AGITG),